Cardiometabolic Health Congress

JULY 17, 2024

Aprocitentan (Tryvio) Approved: March 20, 2024 Indication: Hypertension in adults Administration: Oral Mechanism: Endothelin A and B receptor antagonist Developer: Idorsia Pharmaceuticals Significance: First and only FDA-approved endothelin receptor antagonist for high blood pressure that remains uncontrolled with existing treatments.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

Physiologically Speaking

DECEMBER 15, 2023

Effects of resistance training on traditional CVD risk factors Blood pressure Resistance exercise training has been shown to improve resting blood pressure in cohorts of healthy adults and adults with varying levels of high blood pressure.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Physiologically Speaking

DECEMBER 15, 2023

Effects of resistance training on traditional CVD risk factors Blood pressure Resistance exercise training has been shown to improve resting blood pressure in cohorts of healthy adults and adults with varying levels of high blood pressure.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

DAIC

DECEMBER 8, 2023

There is clearer focus on risk factor modification—for example, weight loss and obesity prevention, physical activity, smoking cessation, limiting alcohol, and controlling blood pressure and other comorbidities—to help prevent AFib or ameliorate any recurrences or worsening of the disease.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Stroke Strokes 52

DAIC

MAY 16, 2024

Among those ages 65 and older, nearly 50% who underwent limb amputation died within one year after surgery, according to the 2024 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association. All patients with PAD should be treated with high-intensity statin therapy.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Quality of Life Ischemia 105